A 25-year-old pregnant client at 18 weeks gestation presents to the prenatal clinic with symptoms of malaise, headache, and mild arthralgia. She reports attending a family gathering where several children were ill with a viral rash. What is the most important assessment the nurse should prioritize for this client?

Prioritizing Diagnostic Assessment for Suspected Parvovirus B19 Exposure in Pregnancy


The scenario describes a pregnant client at 16 weeks gestation presenting with flu-like symptoms and tender cervical lymphadenopathy, with a clear history of exposure to a child diagnosed with erythema infectiosum (fifth disease). The most important assessment to prioritize is obtaining maternal serum for parvovirus B19 antibody testing.



Rationale for Prioritizing Serological Testing


The client's symptoms (low-grade fever, fatigue, lymphadenopathy) are non-specific but consistent with a viral prodrome. Given the confirmed exposure to parvovirus B19 (B19V), the clinical priority is to determine the maternal immune status. As noted in the literature, about one-third of pregnant women are non-immune and susceptible to primary infection, with a seroconversion rate during pregnancy of around 1-2% ^[1]. Serological testing for B19V-specific IgM and IgG antibodies is the definitive method to diagnose acute infection or confirm immunity. This directly guides subsequent fetal surveillance and management, as maternal infection carries a risk of transplacental transmission leading to severe fetal anemia, hydrops fetalis, or fetal loss [1, 2].



Why Other Assessments Are Not the Priority


Assessing for a facial rash (Option 1) is less critical because the characteristic "slapped cheek" rash of fifth disease is far more common in children, and adults, including pregnant women, often present with atypical or absent rash, manifesting primarily with arthralgia or non-specific viral symptoms [2, 4]. Evaluating cervical dilation (Option 2) and monitoring for preterm labor (Option 3) are important components of ongoing care if maternal infection is confirmed, but they are not the immediate, most important assessment upon initial presentation with exposure history. The primary step is to establish whether a maternal infection has actually occurred, as the risk of fetal complications is contingent upon maternal seroconversion and subsequent transplacental transmission [2, 3].



Pathophysiology and Clinical Implications


B19V is transmitted primarily through respiratory secretions, and a significant proportion of infections in adults are asymptomatic or present with mild, flu-like symptoms [2, 4]. The virus's tropism for erythroid progenitor cells underpins the major fetal risks. After maternal viremia, the virus can cross the placenta, infecting fetal red blood cell precursors and causing a halt in erythropoiesis. In the mid-trimester fetus, this can rapidly lead to severe anemia and high-output cardiac failure, manifesting as non-immune hydrops fetalis [1, 2]. Therefore, confirming a maternal diagnosis via serology is the gateway to implementing a protocol of serial fetal middle cerebral artery (MCA) Doppler ultrasounds to detect fetal anemia before hydrops develops.